Off-target effects occur due to the complex nature of the human body and the challenge of designing drugs that are perfectly selective. Cancer cells often share many molecular targets with normal cells, making it difficult to eliminate cancer cells without affecting healthy ones. Additionally, the heterogeneity of cancer cells and the evolving nature of tumors can contribute to these unintended actions.
